OBJECTIVES To determine the association between obstructive sleep apnea and 30-day risk of cardiovascular complications after major noncardiac surgery.
O bstructive sleep apnea (OSA) is the most common type of sleep-disordered breathing and is characterized by cyclical alterations between pharyngeal collapse and arousals during sleep. 1 Consequently, there are recurrent episodes of nocturnal hypoxemia, hypercapnia, endothelial dysfunction, hypercoagulability, and sympathetic overactivity.
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In the general population, OSA is associated with higher risk of cardiovascular complications 3 such as hypertension, 4 myocardial ischemia, heart failure, 5 arrhythmias, stroke, 6 and sudden cardiac death.
7
General anesthetics, sedatives, and postoperative analgesics are potent respiratory depressants that relax the upper airway dilator muscles and impair ventilatory response to hypoxemia and hypercapnia. 1 Each of these events exacerbates OSA and may predispose patients to postoperative cardiovascular complications. In this respect, perioperative mismanagement of OSA has led to serious medicolegal consequences. 8 However, recent analyses of large database repositories showed conflicting results. Depending on the selected end points, OSA was associated with worse, [9] [10] [11] [12] [13] [14] equivocal, 10,12,15 or better outcome 10,11 after surgery. Uncertainty remains whether unrecognized OSA adversely affects postoperative outcomes. Based on preoperative overnight sleep studies, the Postoperative Vascular Complications in Unrecognized OSA (POSA) study was designed to determine the association between OSA and a composite of cardiac death, myocardial injury, heart failure, thromboembolism, atrial fibrillation, and stroke within 30 days of noncardiac surgery.
Methods

Study Design and Participants
This was a multicenter, prospective cohort study of patients undergoing major noncardiac surgery. Ethics approval was obtained for all participating centers, and all patients provided written informed consent. We reported the trial objectives, design, and methods previously. 16 We recruited patients who were 45 years or older and undergoing major noncardiac surgery (intraperitoneal, major orthopedic, or vascular). Patients were eligible for the study if they had 1 or more risk factors for postoperative cardiovascular events (ie, history of coronary artery disease, heart failure, stroke or transient ischemic attack, diabetes requiring treatment, and renal impairment with preoperative plasma creatinine concentration >1.98 mg/dL [175 μmol/L]). We excluded patients with prior diagnosis of obstructive sleep apnea or undergoing corrective surgery for OSA (eg, tonsillectomy, uvulopalatopharyngoplasty, tracheostomy), or anticipated to require prolonged (>2 days) mechanical lung ventilation after surgery.
Procedures
Patients underwent a preoperative overnight sleep study using a type 3 portable sleep monitoring device (ApneaLink Plus; ResMed). 17 Sleep studies were performed either at home within the preceding month (34.1%) or in the surgical ward on the night before surgery (65.9%). In addition, we used a high-resolution pulse oximeter wristwatch (PULSOX-300i; Konica Minolta Sensing Inc) to monitor oxyhemoglobin saturation. Monitors were applied to the patients by experienced research staff at bedtime and were collected the following morning. Recordings were transferred to the coordinating center for subsequent analysis.
We scored the sleep-associated apnea and hypopnea events according to American Academy of Sleep Medicine criteria (eAppendix 1 in the Supplement). 18 Respiratory event index (REI) was calculated as the number of these events per hour of recording. Mild OSA was diagnosed when REI was 5 to 14.9, moderate OSA when REI was 15 to 30, and severe OSA when REI was greater than 30. 18, 19 Based on the pulse oximetry signals obtained from the wristwatch, we also calculated the oxygen desaturation index (ODI) as the number of events (duration >10 seconds) per hour when there was a decrease in oxyhemoglobin saturation of 4% or more from baseline.
20
Before surgery, research staff interviewed all patients to record their baseline characteristics and risk factors for postoperative cardiovascular complications. Patients also indicated their race and ethnicity from a list of fixed categories, so that differences in OSA by race or ethnicity could be determined. In addition, we assessed patients' risk for OSA using the STOP-Bang (Snoring, Tiredness, Observed Apnea, High Blood Pressure, Body Mass Index, Age, Neck Circumference, and Gender) screening tool (scores range from 0-8, with a score of 0-2 indicating low risk; 3-4, moderate risk; and 5-8, high risk). 21 Patients, the attending surgical team, and research staff who collected the outcome data were blinded to the results of the sleep study, STOP-Bang questionnaire scores, and oximetry recordings until 30 days after surgery. After this time, we referred patients with abnormal sleep study findings to their local sleep clinic for further management of care.
Follow-up
All types of anesthetic techniques were permitted, and surgery was performed according to routine standard of care at each site. After surgery, electrocardiograms and venous blood samples (for measuring plasma cardiac troponin concentrations) were collected at 6 to 12 hours and then daily during the first 3 days after surgery. Additional echocardiograms and lung scans were performed, if clinically indicated, to ascertain the diagnosis of cardiac complications. During the first 3 postoperative nights, we recorded oxyhemoglobin saturation using the PULSOX-300i device. All patients were followed up regularly up to 30 days after surgery. Patients discharged home were contacted by telephone. The interview was conducted in a structured fashion. If patients or their relatives indicated that an event had occurred, we contacted the attending physicians or hospitals to obtain documentation.
Outcomes
The primary outcome was a composite of myocardial injury, cardiac death, congestive heart failure, thromboembolism, new atrial fibrillation, and stroke within 30 days of surgery. The prespecified secondary outcomes were unplanned tracheal intubation or postoperative lung ventilation, readmission to the intensive care unit (ICU), and infections. Details regarding the outcome definitions are listed in eAppendix 2 in the Supplement. All outcome events were evaluated by adjudicators blinded to the results of the sleep study.
Statistical Analysis
We estimated that a sample size of 1200 patients was required to ensure a stable regression model with an anticipated primary event rate of 4%. 16 Crude comparisons among patients with varying severity of OSA was performed using analysis of variance, Kruskal-Wallis test, or χ 2 test, as appropriate. We used Cox proportional-hazards models to determine the association between outcome events and OSA, except for unplanned tracheal intubation or postoperative lung ventilation and readmission to the ICU, for which we used logistic-regression analysis. The independent variables consisted of severity of OSA (severe, moderate, mild, or no disease) and factors previously shown to adversely affect outcomes. 22, 23 These included age, history of coronary artery disease, congestive heart failure, stroke or transient ischemic attack, diabetes mellitus, chronic renal impairment, peripheral vascular disease, chronic obstructive pulmonary disease, abdominal or vascular surgery, and surgery for cancer. In addition, we included baseline variables that were unbalanced in patients with different severity of OSA-ethnicity, history of hypertension, and preoperative use of β-blockers. The proportionality assumption was evaluated by Schoenfeld residuals test. Collinearity was assessed by variance inflation factor, with a cutoff threshold of 10. 24 We also undertook a random-effects (frailty) Cox model to account for possible site-clustering effect. 25 The adjusted hazard ratios (HRs)
for different severity of OSA were compared among groups using χ 2 test.
We used a general linear model to determine the association between nocturnal hypoxia and the primary outcome. In this model, severity of postoperative hypoxia was expressed as ODI. Other covariates included in the model were risk factors for the primary outcome as described above. We repeated the analysis to determine the association between the primary outcome and other measures of nocturnal hypoxia, including the lowest oxyhemoglobin saturation and the duration of oxyhemoglobin desaturation less than 80% and less than 90% recorded.
We also analyzed the primary outcome in prespecified subgroups of patients with the following characteristics: general or regional anesthesia, volatile-based anesthesia or propofol infusion, the number of postoperative nights with supplemental oxygen therapy, receiving (or not receiving) opioids after surgery, using (or not using) patient-controlled analgesia, and whether the surgery was considered minimally invasive. Subgroup analyses were performed using Cox models with the addition of corresponding interaction terms.
To better understand the basis of adverse outcomes, we performed post hoc analyses by repeating the Cox models using individual components of the primary outcome as the dependent variable. In addition, we conducted a sensitivity analysis to determine the validity of myocardial injury as an outcome measure. In this analysis, myocardial injury in the composite primary outcome was replaced by myocardial infarction according to the universal definition. 26 A post hoc comparison of the length of hospital stay in patients with different severity of OSA was also performed using log-rank test. In-hospital deaths were assigned with the longest length of stay.
For the association between outcomes and preoperative risk assessment for OSA based on the STOP-Bang screening tool, we repeated the primary analysis by stratifying patients as low-, intermediate-, and high-risk. We planned to conduct multiple imputations if there were more than 5% missing data on the outcomes or baseline variables included in the regression models. There was no adjustment for multiple comparisons; therefore, the results of the secondary analyses, subgroup analyses, and other analyses should be interpreted as exploratory.
All tests were 2-sided, and P<.05 was designated as statistically significant. Analyses were performed using Stata Release 13 (StataCorp) and R version 3.5.2 (R Project for Statistical Computing).
Results
A total of 1364 patients were recruited from 8 hospitals in 5 countries between January 2012 and July 2017. We excluded 78 patients because sleep recordings (<4 hours) were unsatisfactory for analysis. Another 68 patients were excluded because surgery was canceled and could not be rescheduled within the subsequent month. Overall, 1218 patients who completed a preoperative sleep study and had undergone major noncardiac surgery were included in the current analyses ( Figure 1 ). Among these patients, 67.6% had unrecognized OSA (REI ≥5), 30.5% had at least moderate OSA (REI ≥15), and 11.2% had severe OSA (REI >30). Details of preoperative sleep studies are reported in eTable 1 in the Supplement. All patients completed 30 days follow-up; no imputation of data was performed. Table 1 summarizes patient characteristics, type of surgery, preoperative medications, and results of preoperative sleep studies. A total of 59.8% patients had at least 2 risk factors for cardiac disease. The most commonly performed surgical procedures were intraperitoneal (35.0%) or major orthopedic (29.9%), 42.1% of procedures were performed for cancer, and 28.3% were performed using a minimally invasive approach. Patients with OSA had a higher mean age and higher mean body mass index, and 63.7% were men. These patients had a higher rate of hypertension (85.9%), and 37.3% were taking β-blockers before surgery. The details of anesthetic administration and use of postoperative analgesia are presented in eTable 2 and eTable 3, respectively, in the Supplement. Perioperative anesthetic management was not different between groups. At least 1 postoperative measurement of cardiac troponin concentration was obtained for 95.8% of patients (eTable 4 in the Supplement).
Outcomes
The primary outcome occurred in 235 patients (19.3%) within 30 days of surgery. Among these patients, 17 (1.4%) died of cardiac cause; 205 (16.8%) had myocardial injury; 21 (1.7%) had congestive heart failure; 30 (2.5%) had atrial fibrillation; 10 (0.8%) had thromboembolism; and 5 (0.4%) had stroke. In patients with myocardial injury, 67 (5.5%) had ischemic symptoms, changes in electrocardiogram or cardiac imaging, and fulfilled the diagnosis of myocardial infarction. 26 Age, renal impairment, peripheral vascular disease, and OSA were independent risk factors for postoperative cardiovascular events (eTable 5 in the Supplement). There was no collinearity between variables. The Cox models showed no interaction between severity of OSA and age (P = .06 for interaction), preexisting renal impairment (P = .07 for interaction), and history of peripheral vascular disease (P = .56 for interaction Table 2) . In a sensitivity analysis that replaced myocardial injury with myocardial infarction in the primary outcome, severe OSA remained independently associated with postoperative cardiovascular complications (eTable 7 and eFigure 1 in the Supplement). OSA was also associated with infective outcomes, unplanned tracheal intubation, or postoperative lung ventilation and readmission to the ICU ( Table 2 ). The association between OSA and postoperative cardiovascular events was similar across all subgroups of patients (P > .14 for interaction) (Figure 3) . The associations in subgroup analysis were unchanged with varying severity of OSA (eFigures 2-4 in the Supplement). The median length of hospital stay in all patients was 5 days (interquartile range, 4-8) and was similar between different severities of OSA (P = .08 by log-rank test) (eFigure 5 in the Supplement).
STOP-Bang Score and Outcomes
Based on the preoperative STOP-Bang risk score questionnaire, 317 patients (26.3%) were rated as at high risk for OSA, 
Postoperative Nocturnal Oximetry Monitoring
A total of 1131 patients (92.9%) received nocturnal oximetry monitoring during the first night after surgery, 1076 (88.3%) during the second night, and 983 (80.7%) during the third night (eFigures 7-9 in the Supplement). In patients without OSA, there was a significant increase in ODI after surgery (P < .001 for general linear model). In contrast, ODI in patients with OSA was reduced during the first 2 nights and returned to baseline on the third night after surgery. These changes were associated with supplemental oxygen administration (P = .009 for general linear model) (eFigure 7 in the Supplement). There was no difference in ODI, lowest oxyhemoglobin saturation, and maximum heart rate in patients with and without postoperative cardiovascular events (eTable 12 in the Supplement). However, the mean cumulative duration of oxyhemoglobin desaturation less than 80% during the first 3 postoperative nights for patients with cardiovascular complications (23.1 [95% CI, 15.5-27.7] minutes) was longer than for patients with no cardiovascular complications (10.2 [95% CI, 7.8-10.9] minutes) (P < .001 for general linear model) (eTable 12 and eFigure 10 in the Supplement).
Discussion
In this study of adults undergoing major noncardiac surgery, unrecognized severe obstructive sleep apnea was significantly associated with increased risk of 30-day postoperative vascular complications. Kawetal 27 conducted a meta-analysis of 9 cohort and casecontrol studies (n = 2615 patients) that evaluated the association between OSA and postoperative cardiovascular complications. They reported an increased risk with OSA (odds ratio, 2.07 [95% CI, 1.23-3.50]), but there were few events (event rate, 2.6%), and the studies used less stringent criteria to diagnose OSA and postoperative cardiovascular complications. More recently, the Society of Anesthesia and Sleep Medicine reported a systematic review of 61 studies, including analyses of large-scale national databases, 9-15 to examine the association of OSA with perioperative outcomes. 28 Although a large number of patients were included (N = 8 969 583), there were substantial variations in outcome definitions and duration of follow-up, and the studies reported inconsistent results. In particular, it is unclear whether patients in the control groups of the 61 studies had unrecognized OSA, and those who had a preoperative diagnosis of OSA may have received extra treatment to modify perioperative outcomes. This heterogeneity precluded quantitative analysis of data.
In this study, a representative sample of patients undergoing major noncardiac surgery was included. Standardized preoperative sleep monitoring was performed to diagnose OSA, and patients were stratified according to disease severity. All patients c Elevated jugular venous pressure, respiratory crackles, or presence of third heart sound and at least 1 radiographic feature (vascular redistribution, interstitial edema, or alveolar pulmonary edema).
d Included either pulmonary embolism (confirmed by ventilation-perfusion lung scan, helical computed tomography or pulmonary angiography) or deep venous thrombosis (confirmed by compression ultrasonography, computed tomography, or contrast venography).
e Electrocardiographic documentation of atrial fibrillation occurred after surgery with or without symptoms or treatment.
f New focal neurologic deficit thought to be vascular in origin, with signs or symptoms that last more than 24 hours.
g Unplanned ICU admission or readmission from ward because of perioperative events after surgery.
h Included unplanned invasive or noninvasive (continuous or bi-level positive airway pressure) lung ventilation within 30 days of surgery.
i Infiltrate, cavitation, consolidation, or effusion confirmed by chest radiography or computed tomography, in association with change in sputum production or positive microbial culture of blood or respiratory secretion.
j Purulent discharge from surgical wound with or without a positive microbial culture, or pathogenic organisms isolated from aseptically obtained microbial culture.
k Included those of the urinary tract, upper respiratory tract, and central nervous system.
l Assessed daily in the mornings after surgery using the confusion assessment method.
Association not associated with better outcome. These data are consistent with a retrospective analysis of an administrative database of 30 294 patients with documented OSA undergoing hip or knee arthroplasties with neuraxial block, general anesthesia, or both. 34 The study showed no change in postoperative cardiac or respiratory complications with neuraxial or general anesthesia. However, blood transfusion, requirement for postoperative mechanical lung ventilation, and ICU admission were decreased with neuraxial block. In the current study, patients undergoing major noncardiac surgery were recruited, few received regional blocks, and the majority required larger doses of systemic opioids for postoperative analgesia. This may have limited the statistical power to detect important interactions between OSA, anesthetic techniques, and postoperative analgesia.
Limitations
This study has several limitations. First, electroencephalograms were not recorded in the preoperative sleep studies. Thus, it was not possible to track whether patients were asleep during measurement, and this may have underestimated the severity of OSA. Second, perioperative management was not controlled, but there was no difference in the administration of anesthesia and analgesics in patients with varying degrees of OSA. Although the surgical team was blinded to the results of the preoperative sleep study, recognition of minor a Calculated as weight in kilograms divided by height in meters squared. The following signals were recorded: respiratory flow (nasal pressure), breathing sounds (snore), respiratory effort, heart rate and oximetry.
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Successful monitoring required at least 4 hours of recordings.
Parameters measured:
(1) Apnea event is defined as an episode of airflow reduction ≥ 90% from baseline for ≥ 10 seconds.
(2) Apnea index is the number of apnea events per hour of recording.
(3) Hypopnea event is defined as an episode of airflow reduction ≥ 30% from baseline for ≥ 10 seconds and associated with ≥ 3% oxyhemoglobin desaturation.
(4) Hypopnea index is the number of hypopnea events per hour of recording.
(5) Respiratory event index is the number of apnea and hypopnea events per hour of recording.
PULSOX-300i measurement
The following signals were recorded: pulse oximetry and heart rate.
Parameter measured:
Oxygen desaturation index is the number of events per hour of oximetry recording where oxyhemoglobin saturation decreased by ≥ 4% from baseline for ≥ 10 seconds. Either crackles on physical examinations of chest with one of the followings:
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